Health Care & Life Sciences » Pharmaceuticals | Schnell Biopharmaceuticals Inc.

Schnell Biopharmaceuticals Inc.

Schnell Biopharmaceuticals Inc.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW37.53
Market Cap
KRW250.34 B
Shares Outstanding
214.89 M
Public Float
80.6 M

Profile

Address
Room 301 Gangho Building
Seoul SL 06735
Korea, Republic Of
Employees -
Website http://www.aprogen-pharm.com
Updated 07/08/2019
Aprogen Pharmaceuticals, Inc. engages in the manufacture and sale of pharmaceutical products. It operates throught the Pharmaceutical Manufacturing and Wholesale business divisions. The Pharmaceutical Manufacturing division provides antibiotics, antirhematics, and medicines for dermatopathy.

Financials

View All

Jung-Chool Kim
Chief Executive Officer & Director
Yun-Gyeong Bae
Director & Head-Education